Cypress Asset Management Inc Abbott Laboratories Transaction History

Cypress Asset Management Inc

$357 Million
Q1 2024

A detailed history of Cypress Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Cypress Asset Management Inc holds 27,967 shares of ABT stock, worth $3.24 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

27,967

Previous 24,306 15.06%

Holding current value

$3.24 Million

Previous $2.68 Million 18.8%

% of portfolio

0.89%

Previous 0.82%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 11, 2024	BUY	$109.52 - $120.96 $400,952 - $442,834	3,661 Added 15.06%	27,967 $3.18 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $1,713 - $2,097	19 Added 0.08%	24,306 $2.68 Million
Q3 2023 Feb 09, 2024	BUY	$95.53 - $114.62 $1,050 - $1,260	11 Added 0.05%	24,317 $2.36 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2,015 - $2,245	-20 Reduced 0.08%	24,287 $2.65 Million
Q1 2023 May 25, 2023	SELL	$96.86 - $114.01 $11,138 - $13,111	-115 Reduced 0.47%	24,307 $2.46 Million
Q4 2022 Feb 28, 2023	SELL	$95.06 - $111.52 $139,738 - $163,934	-1,470 Reduced 5.68%	24,422 $2.68 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $46,444 - $53,774	-480 Reduced 1.82%	25,892 $2.51 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $15,820 - $19,122	-155 Reduced 0.58%	26,372 $2.87 Million
Q1 2022 Jun 06, 2022	SELL	$114.02 - $139.04 $404,200 - $492,896	-3,545 Reduced 11.79%	26,527 $3.14 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $16,520 - $20,228	-143 Reduced 0.47%	30,072 $4.23 Million
Q3 2021 Oct 18, 2021	SELL	$116.66 - $129.06 $8,166 - $9,034	-70 Reduced 0.23%	30,215 $3.57 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $62,945 - $74,095	-595 Reduced 1.93%	30,285 $3.51 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $82,283 - $96,941	-756 Reduced 2.39%	30,880 $3.7 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $30,975 - $33,753	-295 Reduced 0.92%	31,636 $3.46 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $18,328 - $22,258	-200 Reduced 0.62%	31,931 $3.48 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $219,449 - $280,868	2,866 Added 9.79%	32,131 $2.94 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $87,319 - $127,685	1,390 Added 4.99%	29,265 $2.31 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $188,424 - $209,760	-2,400 Reduced 7.93%	27,875 $2.42 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $49,104 - $53,244	-600 Reduced 1.94%	30,275 $2.53 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $115,150 - $134,300	-1,580 Reduced 4.87%	30,875 $2.6 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $10,595 - $12,809	-160 Reduced 0.49%	32,455 $2.59 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $95,062 - $107,691	-1,450 Reduced 4.26%	32,615 $2.36 Million
Q3 2018 Oct 19, 2018	SELL	$60.81 - $73.36 $28,580 - $34,479	-470 Reduced 1.36%	34,065 $2.5 Million
Q2 2018 Jul 27, 2018	SELL	$57.57 - $63.54 $57,570 - $63,540	-1,000 Reduced 2.81%	34,535 $2.11 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $567,651 - $641,798	-10,088 Reduced 22.11%	35,535 $2.13 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $66,563 - $71,262	-1,240 Reduced 2.65%	45,623 $2.6 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $2.25 Million - $2.51 Million	46,863	46,863 $2.5 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.

Account

Cypress Asset Management Inc Abbott Laboratories Transaction History